23 / 61
LUME LUNG 1: Significant Improvement in Disease
Control Rate by Independent Central Review
Reck M, et al.
Lancet Oncol
. 2014;15:143-55.
CR = complete response; HR = hazard ratio; OR = odds ratio; OS = overall survival; PR = partial response; SD = stable disease; PD = progressive disease.
*Significant improvement in disease control rate with nintedanib + docetaxel
(Odds ratio 1.93;
P
<0.0001 for adenocarcinoma and Odds ratio 1.68,
P
<0.0001 for all patients)